Dr. Krauss is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Drive
Ann Arbor, MI 48109Phone+1 734-647-8902
Education & Training
- University of MichiganFellowship, Hematology and Medical Oncology, 1988 - 1992
- University of MinnesotaResidency, Internal Medicine, 1985 - 1988
- University of Michigan Medical SchoolClass of 1985
Certifications & Licensure
- MI State Medical License 1988 - 2025
- OR State Medical License 1969 - 2016
- OH State Medical License 1994 - 2006
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- S0820, Adenoma and Second Primary Prevention Trial Start of enrollment: 2013 Aug 23
- Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer Start of enrollment: 2012 Nov 14
- Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR Start of enrollment: 2013 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 298 citationsOrgan Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy.Julio Garcia-Aguilar, Sujata Patil, Marc J Gollub, Jin K Kim, Jonathan B Yuval
Journal of Clinical Oncology. 2022-08-10 - 42 citationsLong-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial.Floris S Verheij, Dana M Omer, Hannah Williams, Sabrina T Lin, Li-Xuan Qin
Journal of Clinical Oncology. 2024-02-10 - 129 citationsSotorasib for previously treated colorectal cancers with KRASmutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial.Marwan G Fakih, Scott Kopetz, Yasutoshi Kuboki, Tae Won Kim, Pamela N Munster
The Lancet. Oncology. 2022-01-01
Journal Articles
- KRASG12C Inhibition with Sotorasib in Advanced Solid TumorsDavid S Hong, Marwan G Fakih, Gregory A Durm, Geoffrey I Shapiro, Gerald S Falchook, Adrian Sacher, Crystal S Denlinger, John C Krauss, Andrew L Coveler, Suresh S Rama..., The New England Journal of Medicine
Press Mentions
- Man with End-Stage Colon Cancer Seeks to Share Knowledge with Fellow PatientsMay 27th, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: